Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation

Matthew Arquette, Todd Wasserman, Ramaswamy Govindan, David Garfield, Neil Senzer, Heidi Gillenwater, Mark Socinski

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation'. Together they form a unique fingerprint.

Medicine & Life Sciences